Age

Ez-PAVE: Lower LDL-C Target Reduces CV Events

Radcliffe CVRM

Higher ARR Linked to AF and Stroke Risk in Older Adults

Radcliffe CVRM

SELECT: Semaglutide Reduces Hospital Admissions

Radcliffe CVRM

High-Dose Flu Vaccine Reduces Hospitalisation in CKD

Radcliffe CVRM

Liraglutide Slows Cognitive Decline in Alzheimer's Trial

Radcliffe CVRM

Balcinrenone Plus Dapagliflozin Cuts Albuminuria in CKD

Radcliffe CVRM

Intensive BP Lowering Improves Retinal Microvasculature

Radcliffe CVRM

LDL-C, Lp(a) & Hs-CRP Predict CV Events Synergistically

Radcliffe Cardiology

Tirzepatide Shows Significant Glycaemic and BMI Improvements in Youth with Type 2 Diabetes

Radcliffe CVRM

EASD 25: EMPIRE-PREVENT: Metabolic Effects of Empagliflozin in Patients at Risk of Heart Failure

Camilla Andersen

Watch time: 6m 28s
Statins Reduce Mortality and CVD in Type 1 Diabetes for Primary Prevention

Radcliffe CVRM

Joost Daemen, Nicolas M Van Mieghem

Watch time: 5h 48m 39s (30 videos)

Joost Daemen, Nicolas M Van Mieghem

Watch time: 5h 48m 39s (30 videos)
Higher ARR Linked to AF and Stroke Risk in Older Adults

Radcliffe CVRM

SELECT: Semaglutide Reduces Hospital Admissions

Radcliffe CVRM

Ez-PAVE: Lower LDL-C Target Reduces CV Events

Radcliffe CVRM

Statins Reduce Mortality and CVD in Type 1 Diabetes for Primary Prevention

Radcliffe CVRM

LDL-C, Lp(a) & Hs-CRP Predict CV Events Synergistically

Radcliffe Cardiology

Balcinrenone Plus Dapagliflozin Cuts Albuminuria in CKD

Radcliffe CVRM

Liraglutide Slows Cognitive Decline in Alzheimer's Trial

Radcliffe CVRM

High-Dose Flu Vaccine Reduces Hospitalisation in CKD

Radcliffe CVRM

New Multi-Ancestry Polygenic Score Improves BMI and Obesity Prediction Across the Lifespan

Radcliffe CVRM

Clinical Presentations and Treatment: Focus on CKD and CVD

Stephan Von Haehling, , , et al

Watch time: 1h 10s
EASD 25: EMPIRE-PREVENT: Metabolic Effects of Empagliflozin in Patients at Risk of Heart Failure

Camilla Andersen

Watch time: 6m 28s

About

Advancing age is a primary driver of heart failure incidence and complexity. Older patients present unique clinical challenges: atypical symptoms, multiple comorbidities, polypharmacy, and heightened vulnerability to frailty and functional decline. This section of Heart Failure Academy curates expert commentary, late-breaking trial coverage, and evidence-based educational content focused on age-related heart failure — equipping clinicians with the knowledge to optimise risk stratification, tailor therapeutic strategies, and improve outcomes in this growing patient population.

Articles